Bristol-Myers Squibb Co (BMY)
43.76
-0.34
(-0.78%)
USD |
NYSE |
May 17, 11:48
Bristol-Myers Squibb Total Long Term Debt (Quarterly): 55.68B for March 31, 2024
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 55.68B |
December 31, 2023 | 39.77B |
September 30, 2023 | 37.60B |
June 30, 2023 | 37.68B |
March 31, 2023 | 37.83B |
December 31, 2022 | 39.32B |
September 30, 2022 | 39.10B |
June 30, 2022 | 42.06B |
March 31, 2022 | 44.97B |
December 31, 2021 | 44.55B |
September 30, 2021 | 44.74B |
June 30, 2021 | 45.16B |
March 31, 2021 | 46.28B |
December 31, 2020 | 50.68B |
September 30, 2020 | 44.95B |
June 30, 2020 | 46.67B |
March 31, 2020 | 46.71B |
December 31, 2019 | 46.73B |
September 30, 2019 | 24.96B |
June 30, 2019 | 24.98B |
March 31, 2019 | 6.016B |
December 31, 2018 | 7.349B |
September 30, 2018 | 7.307B |
June 30, 2018 | 7.387B |
March 31, 2018 | 7.70B |
Date | Value |
---|---|
December 31, 2017 | 7.962B |
September 30, 2017 | 8.443B |
June 30, 2017 | 8.217B |
March 31, 2017 | 8.434B |
December 31, 2016 | 6.708B |
September 30, 2016 | 6.826B |
June 30, 2016 | 6.736B |
March 31, 2016 | 6.699B |
December 31, 2015 | 6.689B |
September 30, 2015 | 7.274B |
June 30, 2015 | 7.37B |
March 31, 2015 | 7.457B |
December 31, 2014 | 7.832B |
September 30, 2014 | 7.668B |
June 30, 2014 | 7.737B |
March 31, 2014 | 7.648B |
December 31, 2013 | 8.34B |
September 30, 2013 | 7.212B |
June 30, 2013 | 7.206B |
March 31, 2013 | 7.894B |
December 31, 2012 | 7.394B |
September 30, 2012 | 7.359B |
June 30, 2012 | 5.445B |
March 31, 2012 | 5.415B |
December 31, 2011 | 5.491B |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
24.96B
Minimum
Sep 2019
55.68B
Maximum
Mar 2024
42.02B
Average
44.65B
Median
Total Long Term Debt (Quarterly) Benchmarks
Amgen Inc | 64.02B |
Gilead Sciences Inc | 25.19B |
Johnson & Johnson | 33.63B |
Eli Lilly and Co | 26.21B |
2seventy bio Inc | 0.00 |